Showing results (111-120 of 17,194) with videos related to
Sort By:
Pageof 1,720
Surgery, Gynecology & Obstetrics|May 1, 1986
Complications of extensive adhesion formation after intraperitoneal chemotherapyM Markman, S Cleary, S B Howell, et al.Cancer Research|June 1, 1986
Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartateT C Chan, M Markman, S Cleary, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamoleM Markman, T C Chan, S Cleary, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancerS B Howell, S Kirmani, W E Lucas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Totally implantable system for peritoneal accessC E Pfeifle, S B Howell, M Markman, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
The cellular pharmacology of oxaliplatin resistanceM Mishima, G Samimi, A Kondo, et al.Cancer Research|December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineP Naredi, D D Heath, R E Enns, et al.Cancer Treatment Reports|September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose scheduleT N Campbell, S B Howell, C Pfeifle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusionS Zimm, S M Cleary, C N Horton, et al.Molecular Pharmacology|November 28, 2001
Identification of genes that mediate sensitivity to cisplatinH Niedner, R Christen, X Lin, et al.Pageof 1,720